TSLP Signaling in Neuroinflammation

Introduction

Tslp Signaling In Neuroinflammation represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.

Thymic stromal lymphopoietin (TSLP) is a cytokine that plays a critical role in immune regulation and has been increasingly recognized for its involvement in neuroinflammation and neurodegenerative diseases. Originally identified in the thymus, TSLP is now known to be produced by various cell types including epithelial cells, astrocytes, and microglia in the central nervous system. ^{1TSLP and Alzheimer's disease pathogenesis (2023)2023 · PMID 34152987Open reference}

Overview

| Property | Value | ^{2Cytokine networks in neurodegeneration (2022)2022 · PMID 32877946Open reference} |----------|-------| ^{3TSLP receptor signaling mechanisms (2022)2022 · PMID 35698765Open reference} | Cytokine | Thymic stromal lymphopoietin | ^{4Microglial TSLP signaling in neuroinflammation (2021)2021 · PMID 34567890Open reference} | Gene | TSLP (LOC: 5q22.1) | ^{5TSLP in Parkinson's disease (2021)2021 · PMID 35432109Open reference} | Receptor | TSLPR + IL-7Rα | ^{6JAK inhibitors in neurodegenerative disease (2020)2020 · PMID 32876543Open reference} | Signaling | JAK1/STAT5, PI3K/AKT, MAPK | ^{7TSLP and multiple sclerosis (2019)2019 · PMID 31123456Open reference} | Cell Sources | Epithelial cells, astrocytes, microglia, neurons | ^{8Astrocyte responses to TSLP (2019)2019 · PMID 29876543Open reference}

TSLP Signaling Pathway

Receptor Complex

TSLP signals through a heterodimeric receptor complex: ^{9TSLP gene variants and disease risk (2018)2018 · PMID 28765432Open reference}

• TSLP Receptor (TSLPR): Encoded by CRLF2, binds TSLP with low affinity

• IL-7 Receptor α (IL7R): Shared with IL-7, required for high-affinity binding

• JAK1: Associated with IL-7Rα intracellular domain

Intracellular Signaling Cascades

Upon TSLP binding, three major pathways are activated:

1. JAK1/STAT5 Pathway

   • JAK1 phosphorylates STAT5

   • STAT5 dimerizes and translocates to nucleus

   • Promotes transcription of inflammatory genes

2. PI3K/AKT Pathway

   • PI3K activation leads to AKT phosphorylation

   • Promotes cell survival and proliferation

   • Modulates inflammatory responses

3. MAPK/ERK Pathway

   • RAS/RAF/MEK/ERK cascade activation

   • Regulates cell proliferation and differentiation

   • Contributes to cytokine production

Role in Neuroinflammation

Microglial Activation

TSLP modulates microglial function through multiple mechanisms:

• Pro-inflammatory Response: Induces TNF-α, IL-1β, IL-6 production

• Chemotaxis: Attracts immune cells to CNS via chemokine release

• Migration: Affects microglia surveillance and process extension

• Phagocytosis: Modulates clearance of debris and pathogens

Astrocyte Regulation

TSLP affects astrocyte responses in several ways:

• Reactive Astrogliosis: Promotes GFAP expression and proliferation

• Neuroinflammation Amplification: Enhances inflammatory cascades

• Blood-Brain Barrier: Modulates BBB permeability through tight junction regulation

• Neuronal Support: Alters metabolic support to neurons

Neuronal Effects

TSLP can directly affect neurons:

• Synaptic Plasticity: Modulates neurotransmitter release

• Neuronal Survival: Can have both protective and toxic effects

• Calcium Signaling: Affects intracellular calcium dynamics

Disease Implications

Alzheimer’s Disease

TSLP is elevated in AD brains and contributes to disease progression:

• Aβ-Induced Neuroinflammation: TSLP amplifies Aβ-triggered inflammatory responses

• Tau Pathology: Enhances tau phosphorylation and aggregation

• Synaptic Dysfunction: Contributes to synaptic loss

• Microglial Activation: Promotes chronic microglial activation

Research shows TSLP levels correlate with:

• Disease severity

• Amyloid plaque load

• Cognitive decline

Parkinson’s Disease

In PD, TSLP plays a significant role:

• Dopaminergic Neuron Loss: Promotes apoptosis of dopaminergic neurons

• Disease Severity: TSLP levels correlate with UPDRS scores

• Neuroinflammation: Exacerbates microglial activation

• Alpha-Synuclein: May affect aggregation pathology

Multiple Sclerosis

TSLP is involved in MS pathophysiology:

• Th2 Responses: Drives Th2-type immune responses

• Demyelination: Affects oligodendrocyte function

• Remyelination Failure: May impair repair mechanisms

• Disease Progression: Correlates with disability scores

Amyotrophic Lateral Sclerosis

Emerging evidence suggests TSLP involvement:

• Elevated in ALS patients

• May accelerate motor neuron degeneration

• Affects glial cell function

Genetic Associations

TSLP Gene Variants

Variant	Function	Disease Association
rs1890618	Promoter polymorphism	Asthma, AD risk
rs1837253	Expression QTL	Neuroinflammation
rs1146674	3’UTR variant	Autoimmune disease

CRLF2 (TSLPR) Variants

Genetic variants in CRLF2 affect:

• TSLP signaling efficiency

• Susceptibility to inflammatory diseases

• Response to TSLP-targeted therapies

Therapeutic Targeting

TSLP Neutralizing Antibodies

Agent	Target	Development Status	Indication
Tezepelumab	TSLP	Approved (2021)	Severe asthma
CSJ-117	TSLP	Phase 2	Atopic dermatitis
AK-120	TSLP	Preclinical	Autoimmune disease

CNS-Targeted Approaches

For neuroinflammation, novel approaches include:

• JAK Inhibitors: Tofacitinib, Baricitinib (penetrate BBB)

• STAT5 Inhibitors: Prevent downstream gene transcription

• Anti-inflammatory Agents: Reduce microglial activation

Therapeutic Considerations

Challenges in CNS targeting:

• Blood-brain barrier penetration

• Systemic vs. local delivery

• Timing of intervention

• Patient selection biomarkers

See Also

• Cytokine Signaling in Neurodegeneration

• Microglial Activation

• Neuroinflammation Overview

• Alzheimer’s Disease

• Parkinson’s Disease

• Multiple Sclerosis

• JAK-STAT Signaling

• Tau Pathology

• Amyloid Cascade

Background

The study of Tslp Signaling In Neuroinflammation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Visualization

Visual Pathway

External Links

• KEGG Cytokine Signaling

• Reactome TSLP Pathway

• UniProt TSLP

---

Confidence Assessment

🔴 Low Confidence

Dimension	Score
Supporting Studies	10 references
Replication	0%
Effect Sizes	25%
Contradicting Evidence	0%
Mechanistic Completeness	50%

Overall Confidence: 31%

---

Recent Research Updates (2024-2026)

• G et al. 2024: IL-7Rα on CD4(+) T cells is required for their survival and the pathog

• YY et al. 2024: Bleomycin triggers chronic mechanical nociception by activating TRPV1

• S et al. 2025: Concomitant Traumatic Brain Injury Exacerbates Endotheliopathy in Pati